Preising Markus N, Abura Michaela, Jäger Melanie, Wassill Klaus-Heiko, Lorenz Birgit
a Department of Ophthalmology , Justus-Liebig University Giessen , Giessen , Germany.
Ophthalmic Genet. 2017 May-Jun;38(3):252-259. doi: 10.1080/13816810.2016.1210651. Epub 2016 Aug 2.
CLN3 is a rare lysosomal storage disorder. The majority of the patients suffer from neurological degeneration in the first decade of life leading to death in the second or third decade. One of the first symptoms is a rapid visual decline from retinal degeneration. The aim of this study was to correlate the retinal changes in CLN3 as seen with spectral domain optical coherence tomography (SD-OCT) with functional data in patients in the first years after the subjective onset of ocular symptoms.
Three unrelated children aged from 5.6 to 8.8 years, and with molecularly confirmed CLN3, underwent a comprehensive ophthalmological examination including visual acuity, fundus photography, fundus autofluorescence (FAF), electrophysiology (multifocal ERG), Goldmann visual fields, and SD-OCT.
A predominant loss of the first and second neuron retinal layers progressing from the macula to the periphery was identifed. The retinal nerve fibre layer (RNFL) displayed gliosis and an irregular lining of the inner limiting membrane. Compared to the preferential reduction of photoreceptor layer thickness in other maculopathies with pan-retinal involvement, the thickness of the first and second neuron layers was reduced simultaneously in CLN3. Functional testing by multifocal ERG reflected the degenerative progress. Semiquantitative evaluation revealed a generally reduced FAF.
This is the first detailed morphological evaluation of CLN3 patients in the first years after the subjective onset of ocular symptoms. CLN3 is characterized by an early degeneration predominant of the first and second neuron compared to other macular and generalized retinal dystrophies. Imaging is instrumental for early diagnosis and gene-directed molecular analysis of this fatal disorder.
CLN3病是一种罕见的溶酶体贮积症。大多数患者在生命的第一个十年出现神经退行性变,在第二个或第三个十年导致死亡。最早出现的症状之一是视网膜变性导致的视力迅速下降。本研究的目的是将CLN3患者经光谱域光学相干断层扫描(SD-OCT)观察到的视网膜变化与眼部症状主观发作后最初几年患者的功能数据进行关联。
3名年龄在5.6至8.8岁、经分子确诊为CLN3病的非亲属儿童接受了全面的眼科检查,包括视力、眼底照相、眼底自发荧光(FAF)、电生理学(多焦视网膜电图)、Goldmann视野检查和SD-OCT。
发现从黄斑向周边发展的第一和第二神经元视网膜层有明显缺失。视网膜神经纤维层(RNFL)显示胶质增生和内界膜不规则排列。与其他累及全视网膜的黄斑病变中光感受器层厚度优先减少相比,CLN3病中第一和第二神经元层的厚度同时减少。多焦视网膜电图功能测试反映了退行性进展。半定量评估显示FAF普遍降低。
这是对CLN3病患者眼部症状主观发作后最初几年进行的首次详细形态学评估。与其他黄斑和全身性视网膜营养不良相比,CLN3病的特征是第一和第二神经元早期退化占主导。影像学检查有助于对这种致命疾病进行早期诊断和基因导向的分子分析。